Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GILD save search
Kite’s CAR T-cell Therapy Yescarta® First in Europe to Receive Positive CHMP Opinion for Use in Second-line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
Published: 2022-09-16 (Crawled : 12:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.12%
H: 1.31%
C: 0.8%
yescarta europe chmp t-cell positive therapy
CHMP Adopts Positive Opinion to Extend Indication of Veklury® (Remdesivir) for the Treatment of Pediatric Patients with COVID-19
Published: 2022-09-16 (Crawled : 11:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.12%
H: 1.31%
C: 0.8%
covid-19 veklury treatment chmp positive
Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through Education Equity
Published: 2022-09-13 (Crawled : 20:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: -3.41%
awards education health
Global Pulmonary Arterial Hypertension Drug Market to Surpass US$ 11,220.2 Million by 2030 - Coherent Market Insights
Published: 2022-09-13 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -4.98%
H: 7.63%
C: 2.67%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.55%
H: 0.42%
C: -0.72%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -0.6%
H: 0.41%
C: -0.76%
UTHR | $237.12 0.08% 47K
|
Health Technology
|
| O: 0.63%
H: 0.81%
C: 0.57%
MNKD | $4.105 0.61% 260K
|
Health Technology
|
| O: 0.0%
H: 5.91%
C: 3.67%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -1.06%
H: 1.63%
C: 1.2%
drug global hypertension market
Global Cell Therapy Manufacturing Market to Reach $6.01 Billion by 2026
Published: 2022-09-13 (Crawled : 11:00) - prnewswire.com
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: -1.17%
H: 0.15%
C: -1.47%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.72%
H: 0.07%
C: -1.27%
CTLT | $55.965 0.3% 100K
|
Health Technology
|
| O: -2.7%
H: 0.52%
C: -1.7%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: -3.41%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
global therapy market
AIDS Walk Los Angeles Returns In-Person on October 16 in West Hollywood
Published: 2022-09-08 (Crawled : 00:00) - prnewswire.com
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.18%
H: 1.22%
C: 0.46%
angeles
Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published: 2022-09-06 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
UCBJY | $63.676 7.2K
|
Manufacturing
|
| O: 0.73%
H: 2.28%
C: 1.72%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.65%
H: 0.93%
C: 0.71%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: 0.03%
H: 1.18%
C: 0.13%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: -0.03%
H: 1.08%
C: 0.84%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.44%
H: 2.03%
C: 1.76%
CPIX | $1.65 110
|
Health Technology
|
| O: -4.52%
H: 7.12%
C: 5.69%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.24%
H: 1.04%
C: 0.82%
drug market
Jounce Therapeutics Reports Results from Phase 2 Randomized SELECT Trial Testing 2 Different Doses of Vopratelimab in TISvopra Biomarker-Selected Patients
Published: 2022-08-30 (Crawled : 13:00) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: -20.58%
H: 0.0%
C: 0.0%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.1%
H: 0.29%
C: -0.02%
trial therapeutics results phase 2
Gilead Demonstrates Strength of Oncology Portfolio Across Diverse Tumor Types at ESMO Congress 2022
Published: 2022-08-29 (Crawled : 13:20) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.38%
H: 1.17%
C: 0.52%
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors
Published: 2022-08-25 (Crawled : 12:20) - prnewswire.com
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.36%
H: 0.13%
C: -0.41%
CERS | News | $1.675 2.13% 200K
|
Health Technology
|
| O: 1.1%
H: 1.3%
C: 0.43%
BLFS | News S | $15.845 -0.1% 47K
|
Health Technology
|
| O: 1.63%
H: 2.4%
C: 2.36%
solutions therapy
Everest Medicines Announces Interim Results for First Half of 2022
Published: 2022-08-24 (Crawled : 13:20) - prnewswire.com
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -0.13%
Kronos Bio Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Lanraplenib in Combination with Gilteritinib in Acute Myeloid Leukemia
Published: 2022-08-22 (Crawled : 13:00) - biospace.com/
KRON | $1.03 6.8K
|
Health Technology
|
| O: -1.64%
H: 1.19%
C: -4.53%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.2%
H: 0.06%
C: -1.3%
leukemia trial acute myeloid leukemia phase 2b
Gilead Announces First Global Regulatory Approval of Sunlenca® (Lenacapavir), the Only Twice-Yearly HIV Treatment Option
Published: 2022-08-22 (Crawled : 10:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.2%
H: 0.06%
C: -1.3%
sunlenca treatment global hiv approval
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published: 2022-08-19 (Crawled : 14:00) - prnewswire.com
AZNCF | $138.24 800
|
Health Technology
|
| O: 3.04%
H: 0.12%
C: -2.22%
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: -2.05%
H: 0.29%
C: 0.07%
PFE A | $25.615 0.89% 9.9M
|
Health Technology
|
| O: 0.54%
H: 1.24%
C: 0.63%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: 0.01%
H: 2.09%
C: 1.58%
REGN | $894.35 0.04% 140K
|
Health Technology
|
| O: -0.62%
H: 0.57%
C: -0.42%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.25%
H: 1.19%
C: 0.49%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 0.78%
H: 0.49%
C: 0.22%
study market
Gilead Sciences Announces Collaboration With Morehouse School of Medicine and Xavier University of Louisiana College of Pharmacy to Address Inequities in HIV Care
Published: 2022-08-17 (Crawled : 17:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.54%
H: 1.4%
C: 0.08%
care sciences collaboration hiv
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
Published: 2022-08-15 (Crawled : 01:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 1.41%
H: 3.83%
C: 3.7%
trodelvy acquire
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories
Published: 2022-08-15 (Crawled : 00:00) - prnewswire.com
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.08%
H: 0.39%
C: 0.26%
sciences trodelvy agreement
Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study
Published: 2022-08-15 (Crawled : 16:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 1.41%
H: 3.83%
C: 3.7%
cs-02 trodelvy cancer study her2- her2 metastatic breast cancer
Global Engineered T Cells Market Report 2022-2027: Immuno-Oncology Sector Increasing R&D Funding & Expanding Gene Therapy Marketspace Generating High-Potential Opportunities
Published: 2022-08-12 (Crawled : 14:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.51%
H: 0.0%
C: 0.0%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.61%
H: 0.9%
C: 0.73%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: 0.16%
H: 1.53%
C: 1.33%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: 0.61%
H: 23.78%
C: 22.56%
PSTX | News | $2.04 2.0% 120K
|
Health Technology
|
| O: -1.7%
H: 12.62%
C: 8.91%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.42%
H: 0.45%
C: 0.4%
CABA | $13.86 -0.79% 130K
|
Health Technology
|
| O: 2.76%
H: 4.7%
C: 2.68%
BLCM | $0.0748 381.28% 6.1K
|
Health Technology
|
| O: 3.58%
H: 1.99%
C: -1.41%
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.07%
H: 0.54%
C: -0.05%
global report funding therapy market
Prescription Drugs Market Growing to Exhibit a Remarkable Growth of USD 1,482.35 Billion with Analysis of Key Drivers, Size, Share, Growth and Opportunities by 2029
Published: 2022-08-11 (Crawled : 12:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GLAXF | $20.2 510
|
Health Technology
|
| O: -12.81%
H: 8.43%
C: 5.21%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.45%
H: 0.18%
C: -1.47%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -1.83%
H: 0.79%
C: -0.29%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -1.43%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -8.67%
H: 2.89%
C: 2.14%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: -1.18%
H: 1.46%
C: 0.05%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: -0.63%
H: 1.52%
C: 0.09%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: -0.5%
H: 1.88%
C: 1.32%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -10.3%
H: 0.0%
C: 0.0%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.57%
H: 1.0%
C: -0.53%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: -0.02%
H: 0.52%
C: -1.46%
growing growth market
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.